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Objectives: seeding prosthetic grafts with fat-derived microvascular endothelial cells (MVEC) results not only in a non-
thrombogenic EC layer, but also in intimal hyperplasia. Here we investigated incidence, composition, progression, and
cause of this intimal hyperplasia.
Design: EPTFE grafts with MVEC were implanted as carotid interpositions in six dogs with 1 month, and in three dogs
with 4, 8 and 12 months follow-up. Grafts seeded without cells, implanted in the contralateral carotid, served as a control.
In another three dogs labelled cells were seeded to investigate the contribution of the seeded cells (2–3 weeks).
Materials and methods: MVEC were isolated from the falciform ligament. Cells were pressure seeded on ePTFE grafts.
Labelling was performed using retroviral gene transduction. The grafts were analysed with immunohistochemical
techniques.
Results: after 1 month, all patent non-seeded grafts (5/6) showed fibrin and platelet deposition, and all patent seeded
grafts (5/6) were covered with a confluent endothelial monolayer on top of a multilayer of myofibroblasts, elastin and
collagen. After long term follow-up, all non-seeded grafts were occluded, all patent seeded grafts (4 and 12 months) were
covered with an EC-layer with intimal hyperplasia underneath. The thickness of the intima did not progress after 1
month. Transduced cells were found in the endothelial monolayer, hyperplastic intima and luminal part of the prosthesis.
Conclusions: MVEC seeding in dogs results in intimal hyperplasia in all patent grafts, which contains myofibroblasts.
Contaminants from the transplant contribute to this intimal hyperplasia.
Key Words: Microvascular endothelial cells; Cell seeding; In vivo canine model; Small diameter ePTFE vascular grafts;
Intimal hyperplasia; Retroviral gene transduction.
Introduction this reason investigators have looked for other sources
of EC.
Our group first investigated the possibility of usingSeeding autologous endothelial cells onto prosthetic
mesothelial cells (MC) as an alternative for EC. Despitesmall diameter bypasses has been developed to im-
hopeful in vitro results, final in vivo experimentsprove patency.1 This technique has been studied ex-
showed that these cells did not have the desired anti-tensively over the past years with vein-derived EC.
thrombogenic and fibrinolytic properties.8 Sub-Initial results were disappointing as the number of
cutaneous fat tissue was found to be a source of largecells harvested appeared to be too low to cover grafts
amounts of microvascular endothelial cells (MVEC).9confluently. First culturing the cells and subsequently
In vitro experiments with cultured cells, statically andimplanting the seeded graft in a second procedure,
under blood flow conditions showed expectingresulted in favourable outcomes in animal models2–4
results.10,11and in humans.5–7 Due to the need for cell culture,
Via a pressure seeding technique, MVEC can behowever, it failed to become popular among vascular
inserted directly into the crevices of polymericsurgeons. Culture makes the procedure unsuitable for
grafts,9 resulting in a graft ready for implantationurgent cases, cells may grow poorly or may become
within a few minutes. In dogs, MVEC seeding of smallcontaminated, and the procedure is expensive.5 For
diameter expanded polytetrafluoroethylene (ePTFE)
vascular grafts resulted in a statistically significant
∗ Please address all correspondence to: C. H. P. Arts, Department
improvement in graft patency.9,12 So far only a limitedof Surgery (G04.228), University Medical Center Utrecht, P.O. Box
85500, 3508GA Utrecht, The Netherlands. number of human studies have been published13–15
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with quite disappointing results.13,15 The few samples complied with the Guide for the Care and Use of Laborat-
ory Animals, Institute of Laboratory Animal Resources,available for histologic evaluation showed EC on top
of a progressively concentric intimal thickening.13,14 Commission on Life Sciences, National Research Coun-
cil. Washington: National Academy Press, 1996. TwelveIntimal hyperplasia has also been found in
dogs,9,12 but seems to expand more progressively in mongrel dogs, weighing 10–40 kg, were used.
humans,13,14 ultimately leading to graft occlusion.
Aim of this study was to investigate specific char-
acteristics of this MVEC seeding related intimal hy-
Anaesthesiaperplasia, such as the incidence, composition and
progression in time, and the contribution of the seeded
All surgical procedures were carried out as describedcells.
before.8 Just before the first incision, antibiotics (amox-
icillin) were administered, and just before clamping
of the vessels, heparin (100 IE/kg) was given, both i.v.
Methods Postoperatively pain medication (buprenorfine) and
antibiotics (amoxicilline) were administrated i.m., for
Design of the study 4 days.
Exposed ePTFE grafts with falciform derived MVEC
were implanted as carotid interpositions in dogs.
Isolation of microvascular endothelial cells
(a) We studied the incidence and composition of the
intimal hyperplasia, using six dogs with a follow- MVEC were isolated from the falciform ligament.9
up of 1 month; Amounts of fat were incubated for 30 min at 37 °C
(b) Three more dogs with a follow-up of 4, 8 and 12 under continuous vigorous shaking with equal vol-
months were used to investigate the progression umes of crude collagenase obtained from Clostridium
in one year; histolyticum (Sigma-Aldrich Chemie, Steinheim, Ger-
(c) To determine whether the seeded cells contribute to many) (0.4% w/v), BSA (Sigma) (0.4% w/v) in phos-
the intimal hyperplasia, genetically marked MVEC phate buffered saline (PBS), pH 7.4. The digested fat
were seeded in three additional dogs. Follow-up was sieved and centrifuged (1200 rpm; 12 min; room
was 2 weeks for one and 3 weeks for the other temperature (RT)). The pellets were resuspended in
two dogs. Medium 199 (Gibco BRL, Life Technologies, Paisley,
Scotland). The cell suspension was centrifuged againAcetylsalicylic acid, 80 mg a day starting one week
(1100 rpm; 5 min; RT) and the pellet was resuspendedbefore the experiment, was given the first month to
in seeding medium (Medium 199 with autologousprevent platelet aggregation.9 The three dogs whose
serum in a ratio of 6:1).cells were genetically marked before seeding were also
The cells used immediately for seeding were sus-given immunosuppression, 25–50 mg a day starting
pended to a concentration of 2.105 cells/cm2 of graftone week after implantation of the grafts, as expression
surface. The cells used for identification were seededof marker peptides on the cell surface results in the
in a concentration of 1.105 cells/cm2 on fibronectin-development of cytotoxic T-cells.16
coated glass coverslips. The cells used for of geneticAll grafts were implanted as paired grafts, where
labeling were seeded in the same concentration onone graft served as a control. The relation of intimal
Retronectin-coated (Takara Biomedical Group, Shuzohyperplasia to MVEC seeding could be established by
Co, Shigo, Japan) non-tissue-culture-treated plates.implantation a non-seeded graft on the other side.
Possible differences in cell behaviour due to genetic
marking and immunosuppression could be dem-
onstrated by implantation a graft seeded with non- Identification of isolated cells
labelled cells on the other side.
MVEC were cultured in EBM-MV2 Bulletkit culture
medium (Clonetics, BioWhittaker, Verviers, Belgium)/
0.5 M dibutyryl cAMP (Sigma). After confluence, cellsAnimal care
were fixed with 3.5% paraformaldehyde (PFA)/0.1%
Tween. Stains were performed with sheep anti-canineAnimal experiments were approved by the ethics com-
mittee of the University of Utrecht. The animal care von Willebrand Factor (vWF) (Kordia, Leiden, The
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Netherlands), mouse anti-human -actin (DAKO, Glo- Associates, Flagstaff, AZ, U.S.A.) were used. On both
ends luerlock connectors were attached. Half an hourstryp, Denmark), mouse anti-human vimentin (DAKO)
and for visualisation FITC-conjugated goat anti-mouse before MVEC-seeding, the grafts were filled under
pressure, one end closed, with seeding medium toantibody (Becton and Dickinson, Bedford, MA, U.S.A.)
or -rabbit anti-sheep antibody (DAKO). Incubations replace trapped air in the interstices of the graft. The
cell suspension was introduced into the graft with awere done for 45 min at 37 °C, followed by three wash-
steps of 10 min. Cells were visualised with confocal lumbar puncture needle, from bottom to top. Sub-
sequently, a syringe filled with seeding medium, fourlaser microscope (Leica TCS nt, Leica, Heidelberg,
Germany). times the volume of the prosthesis, was attached to
the luerlock connector. The medium was pressed
through the graft in about 1–2 min. Earlier experiments
with a pressure gauge mounted in the system, had
Retroviral gene transduction of isolated cells shown that so the necessary pressure of 5 pounds per
square inch (p.s.i.) was obtained and maintained.9
We used retroviral gene transduction, gene delivery
via a replication deficient retrovirus, to tag cells with
a marker gene which is readily detectable.17 No species-
specific canine marker was available, therefore we Graft implantation
initially employed the widely-used green fluorescent
protein (GFP) marker. Because of autofluorescence of Graft implantation was performed as described be-
the prosthesis, GFP fluorescence was difficult to detect fore.8 A 3–4 cm piece was removed and, to match the
and a GFP-specific antibody was used. Cells of another retraction, a 5 cm graft was implanted.
two dogs were transduced with truncated low affinity
nerve growth factor receptor (LNGFR), a human re-
ceptor. Two days before start of the transduction,
producer cells (Phoenix-GFP, titre 1–2.106 or Frape´-1, Assessment of graft patency
1.107 IU/ml) were plated in different concentrations.17
After 24 h, producer cells with the highest con- The patency of the grafts during follow-up was as-
sessed in three ways. A Doppler investigation wascentration were covered with EBM-MV2 Bulletkit cul-
ture medium without hydrocortison. The next day done, for the first nine dogs after 1 and 4 weeks
and then once a month, for the three dogs of thethis MVEC-medium was harvested, filtered, and after
addition of cAMP and hydrocortison, applied to the transduction experiment weekly. Selective angio-
graphy was performed of all dogs with a follow-upMVEC. Transductions were repeated for 4 and 3 suc-
cessive days in case of GFP- and LNGFR-transduction, of 1 month and of the dog with a follow-up of 12
months, just prior to explantation. In all dogs, anrespectively. One week after isolation transduced and
mock(non)-transduced cells were trypsinised, washed incision was made in the native artery distal to the
graft after more distal cross-clamping, just before ter-and resuspended for seeding as mentioned above.
Small amounts of cells were withheld to determine mination.
the transduction efficiency, defined as the percentage
of cells that express the marker gene. LNGFR-trans-
duced cells were stained with mouse anti-human
Graft explantationLNGFR (200-3-G6-4 (20.4)) (American Type Culture
Collection, Manassa, VA, U.S.A.)/PerPE-conjugated
Graft explantation was performed as described before.8rabbit anti-mouse IgG1 (Southern Biotechnology As-
The grafts were fixed for histology and scanning elec-sociation, Alabama, U.S.A.). Transduction efficiency
tron microscopy (SEM).was established with a flow cytometer (Calibur, Becton
and Dickinson, San Jose´, CA, U.S.A.).
Scanning electron microscopy
Graft preparing and seeding
Sections of the graft were prepared as described
before,8 and examined with a scanning electron micro-Standard ePTFE grafts (8 cm length, 4 mm diameter,
30 m fibril length; generous gift from W. L. Gore & scope (Philips, Eindhoven, The Netherlands).
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Histopathology and immunohistochemistry Immunocytochemical staining of cells cultured on
glass coverslips showed besides vWF-positive cells,
Paraffin slides were made. Haematoxylin and eosin some -actin-positive cells and cells solely positive for
the marker vimentin. The vWF- and vimentin-positive(HE), elastic von Gieson (EvG) and immuno-
histochemical stains were performed. For each dog cells were identified as EC. The percentage of EC
was estimated to be between 50 and 60%, based onthe intimal thickness was determined as follows: for
every graft, four cross sections were taken at a distance immunocytochemistry and morphology, contact in-
hibition. The -actin- and vimentin-positive cells wereof 0.3 cm. For every cross section, at a regular distance
of 300 m, the thickness was measured. For every identified as myofibroblasts. The cells solely positive
for vimentin were identified as fibroblasts, based oncross section, 32 measurements were obtained. The
cell density in the hyperplastic intima was determined their morphology, elongation with branched shoots
without contact inhibition, and the absence of -actinby counting nuclei in circumscribed areas of the same
cross sections (four measurements/cross section). expression (Fig. 1a–c).
Measurements were performed with a light micro-
scope equipped with a JAC-CCD camera (Copen- Incidence and composition of intimal hyperplasia after 1
hagen, Denmark) coupled to a matrox frame grabber month of follow-up
(Matrox Electronic systems Ltd., Quebec, Canada)
Patency. All of the grafts were palpated and found tousing Optimas 6.0 software (DVS, Breda, The Neth-
be open just prior to closure of the wound. In one dogerlands).
no doppler signals were found on both sides after oneImmunohistochemical stainings were preceded by
week, while in the other five dogs bilateral dopplerendogenous peroxidase blocking and citrate boiling,
sounds remained present until the end of the follow-or Triton-serum blocking as in the case of GFP- and
up. Angiography at termination showed bilateral oc-LNGFR-staining. Endogenous peroxidase blocking
clusion in the dog without doppler signals. All otherwas performed with 1.5% H2O2 in phosphate-citrate grafts were patent without any signs of stenosis. Nobuffer (citric acid mono-hydrate 8.32 g/l, Na2HPO4 angiographic difference existed between the MVEC21.52 g/l; pH 5.8±0.1) for 15 min. Citrate boiling was
seeded grafts and the controls. Macroscopic ex-done in citrate buffer (Na3 citrate dihydrate 2.94 g/l; amination at the time of explantation showed that thepH 6.0) for 10 min. Triton-serum blocking was done
occluded grafts had a bluish colour representative ofwith 0.4% Triton X-100/5% horse serum in PBS for
thrombus, no pulsations were present. The other grafts1 h. As primary antibodies sheep anti-canine vWF,
had a white colour and clear pulsations.mouse anti-human -actin, mouse anti-human vi-
mentin, mouse anti-GFP (Clonetech Laboratories, Palo
Histopathology. All patent seeded grafts were coveredAlto, CA, U.S.A.), mouse anti-human LNGFR and
with a neointima, consisting of an intact cell mono-mouse anti-human CD3 (DAKO) were used. Per-
layer, with characteristics of EC, on top of a multilayeroxidase/DAB stainings were done with Vectastain
of cells and fibres (Fig. 2a). The fibres present in theElite ABC Kit and DAB kit for peroxidase staining
intima were identified as collagen and elastin (Fig.(Vector Laboratories, Burlingame, CA, U.S.A.), ac-
2b). The neointima found in all patent seeded graftscording to the manufacturers’ recommendations.
showed a variable thickness in axial as well as trans-
versal direction. The intimal thickness was 143
(116–152) m and the cell density 2.9 (2.9–4.1)×103/Statistical analysis
mm2 (Table 1). All patent non-seeded grafts showed a
covering consisting of fibrin and platelets. Both oc-Results are presented as the median (1st–3rd quartile
cluded grafts, the MVEC seeded and the control, wererange).
filled with a thrombus consisting of platelets and fibrin.
SEM. The patent seeded grafts were covered with aResults
smooth confluent cell layer with EC-morphology. No
fibrin formation was seen, nor signs of platelet ag-Isolation and identification of microvascular endothelial
cells gregates. The occluded grafts and all non-seeded pat-
ent grafts showed activation of coagulation (fibrin and
From the falciform ligament 15–40 g of fat were ob- platelet deposition). No endothelialisation was present
in the patent non-seeded grafts except for the peri-tained. The yield of MVEC was 7 (6.5–8)×105 cells/g.
No growth failures were observed. anastomotic pannus.
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Immunohistochemistry. Cells present in the inner mono-
layer of the neointima which covered all patent seeded
grafts were all vimentin- and vWF-positive, identifying
them as EC (Fig. 2c, e). Cells present in the multilayer
between the monolayer of EC and the prosthesis were
all vimentin- and -actin-positive, classifying them as
myofibroblasts (Fig. 2d, e).
Changes in thickness and composition of the neointima
during a follow-up of 12 months
Patency. Immediately after implantation, the grafts in
the three dogs with a follow-up of 4, 8 and 12 months,
respectively, were palpated and found to be open. At
the time of explantation two of the three seeded grafts
were patent. All non-seeded ones and the seeded one
with a follow-up of 8 months were occluded (Fig. 3).
Doppler investigation showed that the occlusions had
occurred between 1 and 4 weeks of follow-up. Angio-
graphy of the dog with a follow-up of 12 months
showed a patent seeded graft without any signs of
stenosis and an occluded non-seeded graft.
Histopathology. The patent seeded grafts with a follow-
up of 4 and 12 months showed an intact cell
monolayer, with characteristics of EC, covering a
multilayer of cells and fibres (Fig. 3a, b). The intimal
thicknesses after 4 and 12 months were 21 (6–93) m
and 21 (9–47) m, and the cell densities were 3.6
(2.9–5.1)×103/mm2 and 1.7 (0.6–2.2)×103/mm2, re-
spectively (Table 1). No differences were found in
identity of fibres between a follow-up of 1 month
and the longer follow-ups of 4 and 12 months (Fig.
2b). Simular to 1 month of follow-up, a variable
thickness in axial as well as transversal direction
was found. All non-seeded grafts and the graft with
a follow-up of 8 months were occluded with an
organised thrombus, consisting of connective tissue,
cells and microvessels.
SEM. Again, the patent seeded grafts were covered
with a smooth confluent cell layer with EC-mor-
phology, without deposition of fibrin and platelet ag-
gregates.
Fig. 1. Immunocytochemistry of a confluent layer of first passage
canine MVEC. (A) Cells positive for the marker against vWF, and
so identified as EC (magnification, ×560). (B) Cells positive for
the marker against -actin, and so identified as myofibroblasts
(magnification, ×560). (C) Cells solely positive for the marker
vimentin, identified as fibroblasts, based on their morphology
(elongated cells with branched shoots, without contact inhibition)
and the absence of -actin expression (magnification, ×510).
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Fig. 2. Histopathology and immunohistochemistry of the open seeded graft (4 months). (A) HE staining: the cell density of the neointima
(magnification, ×125). (B) EvG staining: the fibres present in the intima are elastin (grey) and collagen (red) (magnification, ×125).
(C) vWF staining: all cells present in the luminal monolayer are positive (brown) and so identified as EC (magnification, ×125). (D) -
actin staining: all cells present in the intima are positive (brown) and so classified as myofibroblasts (magnification, ×125). (E) Vimentin-
staining: all cells present are positive (brown) (magnification, ×125).
Immunohistochemistry. No differences were found transduction efficiency of the LNGFR-transduced cells
was 80% (75–85%) (Fig. 4b′).in identity of cells between follow-up of 1 month
and the longer follow-ups of 4 and 12 months (Fig.
Patency. All grafts seeded with marker-transduced cells2c–e).
were similar to all grafts seeded with mock-transduced
cells in that they remained patent, as suggested by
Contribution of the seeded cells to the intimal hyperplasia Doppler investigation and later proven after ex-
plantation by incision in the native artery distal to theTransduction efficiency. Transduction efficiency of the
GFP-transduced cells was 35% (Fig. 4a′), while the graft.
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Table 1. Median (1st–3rd quartile range) thicknesses and median (1st–3rd quartile range) intimal cell densities of the seeded grafts
with 1–12 months follow-up. The results of two dogs (1 and 8 months follow-up) were not available (n.a.), due to occlusion of the
seeded grafts.
Follow-up 1 month 4 months 8 months 12 months
Dog number 1 2 3 4 5 6 7 8 9
Median thickness (m) n.a. 152 188 116 143 9 21 n.a. 21
Quartile range n.a. 98–192 154–230 100–140 89–174 5–30 6–93 n.a. 9–47
Median cell density n.a. 2.1 4.3 2.9 2.9 4.2 3.6 n.a. 1.7
(×103/mm2)
Quartile range n.a. 1.9–2.7 3.5–5.1 2.4–3.1 2.3–3.5 2.6–5.3 2.9–5.1 n.a. 0.6–2.2
present in the grafts seeded with mock-transduced
cells.
Discussion
Seeding of venous EC has been used to increase the
patency of prosthetic grafts. Although the results were
satisfactory, the technique did not find general ac-
ceptance. The mean reason is that low yield of EC
from veins makes cell culture necessary. To avoid
problems due to cell culture, alternative cells and
sources for EC have been explored. Subcutaneous fat
has been introduced as a source of large numberss ofFig. 3. Macroscopy just after explanation of the grafts (left: open
graft seeded with MVEC, right: occluded graft seeded without MVEC,9–11 being able to form a non-thrombogenic
MVEC). luminal EC layer in vivo. A fat-derived MVEC seeding
related problem, however, is the development of a
thickened intima, which can result in occlusion of the
graft.Histopathology, SEM and immunohistochemistry. In all
dogs, the grafts seeded with transduced cells showed The intimal hyperplasia found after seeding of
MVEC is much more extensive than after seeding ofa similar EC-layer with intimal hyperplasia un-
derneath as the grafts seeded with mock-transduced more pure vein-derived EC, both in humans,18 and in
other species.3 An until now unproven suggestion iscells on the other side, and as the seeded grafts of
both above mentioned experiments without labelled that the neointima, found after seeding of MVEC,
exists of cells seeded on the graft as impurities of thecells.
transplant.5,12
Aim of this study was to investigate specific char-Destination of transduced cells. In all three dogs, marker-
positive cells could be detected in the EC monolayer, acteristics of MVEC seeding-associated intimal hy-
perplasia in terms of incidence, composition, andmultilayer of myofibroblasts and luminal part of the
prosthesis (Fig. 4a, b). No such marker-positive cells progression in time, and the contribution of the seeded
cells. We found that MVEC, isolated from the falciformwere found in the prosthesis seeded with mock-trans-
duced cells. ligament, consisted of a combination of EC, fibroblasts
and myofibroblasts. In all patent seeded grafts a con-
fluent EC lining as well as intimal hyperplasia wasImmunoreaction against transduced cells. A distinct T-cell
infiltrate was present in the neointima covering the present. The thickened intima consisted of a multilayer
of myofibroblasts, elastin and collagen. Thickness andgraft, seeded with marker-transduced cells, and in the
graft itself (Fig. 4c), but not in mock-transduced grafts. cell density of the intima did not progress after 1
month. All patent non-seeded grafts were coveredThis T-cell infiltrate was less abundantly present in
the graft with a follow-up of 2 weeks than in the grafts with platelets and fibrin and did not show any intimal
hyperplasia. After marking the seeded cells we foundwith a follow-up of 3 weeks. The infiltrate was not
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Fig. 4. (A) Immunohistochemistry of a graft seeded with GFP-transduced cells. The intima is visible with positive cells (brown)
(magnification, ×375). (A′) Flow cytometry analysis of GFP-transduced cells. Fluorescence of transduced cells (filled) compared with that
of mock-transduced cells (open). (B) Immunohistochemistry of a graft seeded with LNGFR-transduced cells. Positive cells (black) are
visible in the EC monolayer, the intima and the luminal part of the prosthesis (magnification,×250). (B′) Flow cytometry analysis of LNGFR-
transduced cells. Fluorescence of transduced cells (filled) compared with that of mock-transduced cells (open). (C) Immunohistochemistry of
a graft seeded with transduced cells. A large T-cell infiltrate is present (brown) (magnification, ×250).
that the transplanted cells were present in the EC venous EC were used which are more pure than
MVEC.monolayer, the intima, and the luminal part of the
prosthesis. Retroviral transduction did not affect the results of
cell seeding, as could be established by using a graftHere we have shown for the first time that con-
taminants of the transplant contribute to MVEC-seed- seeded with non-labelled cells as a control. Fur-
thermore the immunosuppression, given to the dogsing related intimal hyperplasia. Using a fluorescent
dye, it has been shown that after 3 weeks of follow- of the transduction experiment, did not affect the
structure of the EC-layer and intimal hyperplasia pres-up, EC lining prosthetic grafts originate from the
seeded cells.19 In another study no evidence was found, ent on the grafts. No differences existed compared to
the EC-layer and intimal hyperplasia present on thehowever, for the hypothesis that intima formation is
due to seeded cells.20 The differences compared to our seeded grafts of both other experiments without
immunosuppression.study were that the seeding density was much lower
than the recommended density we used;6,9 that the Not all cells present in the EC monolayer, intima
and inner third of the prosthesis expressed the marker.polyester used was more porous and such more easily
populated from the surrounding tissue;20 and that The transduction efficiency was not 100%, besides the
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